Interest in understanding psychopathy continued from the nineteenth century into the twentieth century. Based on interviews conducted with hundreds of prisoners, Cleckley formed a narrative conceptualization and description of psychopathic…
Figure 16.1 Treatment algorithm for acute agitation. Table 16.1 Dosing recommendations: conventional antipsychotics Medication (brand) Recommended dose range High-dosing recommendations Recommended plasma concentration Long-acting depot recommendations Chlorpromazine (Thorazine) 300–1000 mg/day…
Figure 31.1 The “Buddi” GPS tracker. Figure 31.2 Example of an exclusion zone for a “geo-fence.” This has parallels with consent to medication and engagement in psychotherapies and occupational activities,…
Figure 30.1 Examples of criminal justice and behavioral health collaborative strategies using a Sequential Intercept Mapping Framework [18,20]. Police-based interventions At the front-end early intercepts, there are evolving trends for…
Figure 21.1 Antipsychotic treatment algorithm. Following several unsuccessful atypical antipsychotic monotherapy trials, a trial with a conventional antipsychotic or with clozapine is recommended. High-dose monotherapy may also be considered for…
Figure 9.1 Heterogeneity of aggression. Identifying the type of aggression a patient is displaying may help guide the selection of appropriate treatments that target the underlying dysfunctional circuits. However, violence…
Figure 28.1 SAMHSA components and principles of recovery for individuals and organizations. Trauma-Informed Perspective There is growing recognition that trauma is widespread, and that the experience of trauma has far-reaching…
Figure 25.1 Forensic‐focused treatment plan cycle. Forensic case formulation Integrating forensic data into a case formulation can prove challenging, but there is some guidance in the literature [2–5,10–12]. In particular,…
Figure 22.1 Relationship between plasma fluphenazine levels and estimated probability of improvement (gray line) and disabling side effects (black line) [20]. Figure 22.2 The relationship between plasma haloperidol and the…
Figure 15.1a Amygdala BOLD responses to social threat (angry faces) before and after 12 weeks of treatment with placebo (n = 10) vs. fluoxetine (n = 3) or divalproex (n…
